VMT Scientific, Inc. Announces Follow Up to Delivery of First Unit
December 08 2005 - 2:32PM
PR Newswire (US)
LAS VEGAS, Dec. 8 /PRNewswire-FirstCall/ -- VMT Scientific, Inc.
(OTC:VMTF) announces follow up to its DEC. 2 press release. It was
stated, "We look forward to the delivery of several of these units
to our PI (Principle Investigator) Dr. Jacques D. Barth, MD, PhD,
FACC, FAHA for his personal inspection. Mr. Kaiser, VMT's Chief
Technical Officer, says the first unit will be available for Dr.
Jacques D. Barth's personal inspection on Friday, Dec. 9th, and
with his approval, we will build and deliver the remaining units.
We request that all visit our new web site at
http://www.vmtf.org/." This Press Release contains forward-looking
statements within the meaning of the "safe harbor" provisions of
the Private Securities Litigation Reform Act of 1995. You should
not place undue reliance on these forward-looking statements. These
statements involve risks and uncertainties that could cause actual
results to differ materially from those suggested in the
forward-looking statements, particularly those risks and
uncertainties inherent in the process of developing, medical
products and Clinical trials. Factors that may cause such a
difference include risks related to VMT Scientific, Inc.'s limited
operating history, risks associated with completing development and
obtaining FDA medical approvals, successful patent protection and
prosecution, successful sale of licensed technology nationally or
internationally. VMT Scientific technology will not meet with
market acceptance, the risk of future warranty and product
liability claims, the uncertainty of VMT Scientifics' future access
to capital to sustain operations, achieve profitability or continue
as a going concern, the failure by VMT Scientific to secure and
maintain relationships with suppliers, manufacturers and other
third parties, reliance on key employees, and dependence on
intellectual property. These forward-looking statements are based
on information and management's expectations as of the date hereof.
Future results may differ materially from our current expectations.
DATASOURCE: VMT Scientific, Inc. CONTACT: Catherine S. Ratelle,
Director of Operations of VMT Scientific, Inc., +1-702-990-3477 Web
site: http://www.vmtf.org/
Copyright